News

Certara Announces Participation in Notable Investor Events

Certara Announces Participation in Notable Investor Events

Certara to Engage Investors in Key Conferences

Certara, Inc. (NASDAQ: CERT), a leading global company in model-informed drug development, has exciting news for investors. The company has announced its participation in prestigious investor conferences designed to showcase its advancements and foster investment opportunities.

Upcoming Conferences

Certara's management team will be present at the following notable events:

UBS Global Healthcare Conference

On Tuesday, November 11, Certara will take the stage at 2:00 PM ET to share insights with investors at the UBS Global Healthcare Conference.

Jefferies Global Healthcare Conference

On Tuesday, November 18, Certara will also participate in the Jefferies Global Healthcare Conference held in London, scheduled for 10:30 AM GMT.

Stephens Annual Investment Conference

Additionally, those interested can catch Certara on the same day, November 18, during the Stephens Annual Investment Conference at 1:00 PM CT.

Access to Live Webcasts

Investors eager to follow the discussions can access live webcasts for each conference through Certara's investor relations platform, which will be available with replays for at least 90 days afterward.

Understanding Certara's Impact

Certara’s mission involves accelerating the process of drug development utilizing advanced biosimulation software and technology. With its innovative approach, Certara collaborates with over 2,400 clients, including biopharmaceutical companies, research institutions, and regulatory entities in more than 70 countries. This wide-reaching network helps shape the future of drug discovery, making it significantly more efficient and effective.

Investor Relations Contact

For any inquiries related to investor relations, reach out to David Deuchler from Gilmartin Group. He will be happy to assist and provide additional insights into Certara's robust strategies.

Contact: ir@certara.com

Media Contact for More Information

For media inquiries, Alyssa Horowitz is available for comments and further information. An engaged media presence helps shine a light on Certara’s innovative contributions to the healthcare industry.

Contact: certara@pancomm.com

Frequently Asked Questions

What is Certara known for?

Certara is renowned for its pioneering role in model-informed drug development, utilizing advanced biosimulation technologies.

When are the upcoming investor conferences?

The conferences are scheduled for November 11 and 18, where Certara's management will present their insights.

How can I access the live conferences?

Live webcasts will be accessible through Certara's investor relations website, with recordings available for 90 days.

What industries does Certara serve?

Certara caters to biopharmaceutical companies, academic institutions, and regulatory agencies worldwide.

Who do I contact for investor relations inquiries?

For inquiries, you can contact David Deuchler at ir@certara.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

111, Inc. Strategizes with Advisors Amid Proposal Talks

Updated Category News Views 62

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

Continue Reading
Cognizant & EBRD Unite for Tech Transformation Push

Updated Category News Views 87

An Unexpected Collaboration to Watch Sometimes partnerships come out of left field, like this one between Cognizant and the European Bank for Reconstruction and Development (EBRD). These two are teaming up to inject some serious tech smarts into the Bank's operations over the next five years. What's interesting here is the role AI and automation play in their grand...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 65

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Docusign and SAP Team Up for Seamless Business Flow

Updated Category News Views 63

Docusign Brings Its A-Game with SAP Partnership Waking up to find Docusign (NASDAQ:DOCU) teaming up with SAP is like getting a surprise deal at the Saturday market—unexpected but welcome. These two giants in their respective fields are joining forces to plant Docusign’s Intelligent Agreement Management (IAM) directly into SAP Sales Cloud and SAP SuccessFactors. If...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 629

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 268

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 219

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 340

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 100

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Reimagining Water: A Crisis and a Call to Action

Updated Category News Views 57

Time for a Change The head of the World Water Council, Loïc Fauchon, didn't mince words at the 9th Cairo Water Week. He proclaimed the old methods of water management are sinking under a flood of modern challenges. Toss in climate upheavals, ballooning cities, and unpredictable diets, and you've got yourself a swirling mess that traditional strategies just can’t mop...

Continue Reading

Top 5 Most Recently Viewed Articles

AFS Partners with Bedrock to Enhance Loan Servicing Solutions

Updated Category News Views 560

AFS's Strategic Partnership with Bedrock Servicing Automated Financial Systems, Inc. (AFS) has established itself as a pivotal investor and partner for Bedrock Servicing, Inc., a company dedicated to pioneering solutions in commercial loan servicing. Together, they aim to leverage innovative technology to captivate the burgeoning private credit and asset management...

Continue Reading
Anticipating a Surge in Pennsylvania Homebuying Trends

Updated Category News Views 181

Understanding the Current Pennsylvania Housing Market Recent trends indicate a significant shift in Pennsylvania's housing market, with realtors anticipating an influx of homebuying interest. The median home sales price has shown a notable increase of 6.4% in August, reaching $319,250. This reflects a rise from $300,000 reported in the previous year, marking a steady...

Continue Reading
Bank of America's CashPro App Surpassing $1 Trillion in Payments

Updated Category News Views 260

Bank of America's CashPro App Achieves Major Milestone Bank of America is celebrating significant advancements in digital payments. The renowned CashPro App is projected to surpass a monumental $1 trillion in payment approvals by year’s end. This remarkable achievement demonstrates the growing reliance of corporate clients on mobile technology for their treasury needs....

Continue Reading
Serac Healthcare's Promising Advances in Endometriosis Imaging

Updated Category News Views 139

Serac Healthcare's End of Phase II Meeting Highlights Serac Healthcare Limited, a clinical radiopharmaceutical company, has recently concluded a significant meeting with the US Food and Drug Administration (FDA) regarding its innovative molecular imaging agent. The company shared positive feedback concerning the design of the upcoming Phase III trial for its diagnostic...

Continue Reading
Kidz Gym and Developmental Pathways Host Creative Families' Night

Updated Category News Views 233

Exciting Families' Night Out at Kidz Gym Kidz Gym is thrilled to announce a spectacular event, the Ultra Families' Night Out, designed for families with children facing developmental challenges. This unique gathering aims to provide an enjoyable and inclusive environment, where children can have a great time while parents enjoy moments of creativity and relaxation. Fun...

Continue Reading